FDA Alerts
FDA Approves First Botulism Antitoxin
The US Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin.
Inhaler Discontinued to Save the Planet
As part of an international agreement to discontinue the use of chlorofluorocarbons that damage the environment, a leading over-the-counter asthma inhaler will not be available next year.